Basis of Presentation (Details) - USD ($)	Feb. 20, 2020	Mar. 15, 2020
Progenics Pharmaceuticals Inc
Business Acquisition [Line Items]
Shares to be received from acquisition conversion (in shares)	0.31
Percentage of net sales, contingent consideration	40.00%
Percentage of total contingent consideration under CVRs	19.90%
Percentage of acquired interest	40.00%
Cash Payments 2022 \| Progenics Pharmaceuticals Inc
Business Acquisition [Line Items]
Contingent consideration value	$ 100,000,000
Cash Payments 2023 \| Progenics Pharmaceuticals Inc
Business Acquisition [Line Items]
Contingent consideration value	$ 150,000,000
Bridge Loan \| Progenics Pharmaceuticals Inc
Business Acquisition [Line Items]
Debt, face amount		$ 10,000,000.0
Debt, stated interest rate		9.50%

Business Combination, Contingent Liability, Contingent Value Right, Percentage Of Net Sales

No definition available.

Name:	lnth_BusinessCombinationContingentLiabilityContingentValueRightPercentageOfNetSales
Namespace Prefix:	lnth_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Business Combination, Contingent Liability, Contingent Value Right, Percentage Of Total Consideration

+ References

No definition available.

+ Details

Name:	lnth_BusinessCombinationContingentLiabilityContingentValueRightPercentageOfTotalConsideration
Namespace Prefix:	lnth_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Business Combination, Right To Receive, Share

+ References

No definition available.

+ Details

Name:	lnth_BusinessCombinationRightToReceiveShare
Namespace Prefix:	lnth_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of voting equity interests acquired at the acquisition date in the business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Face (par) amount of debt instrument at time of issuance.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

+ Details

Name:	us-gaap_DebtInstrumentFaceAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Contractual interest rate for funds borrowed, under the debt agreement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_BusinessAcquisitionAxis=lnth_ProgenicsPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=lnth_CashPayments2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=lnth_CashPayments2023Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=lnth_ProgenicsPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: